This webinar took place on Thursday September 26th, 2019 12:00 PM EST
With 72% of studies running more than one month behind schedule, study delays can cost sponsors millions of dollars for each day that a trial delays a product’s development and launch. Add this to the cost of initiating a site, and your clinical trial can quickly fall into a significant investment into your resources. From site identification through site initiation, are there any ways to streamline study start-up?
This webinar discussed the tactics that sponsors and CROs should consider implementing into their start-up procedures to minimize the likelihood of delays and streamline the early phases of their clinical trials. By identifying ways to streamline site identification, site selection, contract and budget negotiations, and regulatory affairs, sponsors and CROs can optimize the study start-up process and meet enrollment ahead of schedule.
Learning objectives:
1. Understand the specific hurdles that lead to delays in study start-up
2. Identify strategies to accelerate study start-up and minimize delays
3. Know how to implement these strategies into a study team’s workflow
Access “Accelerating Study Start-up” Recording
PRESENTER:
Charlie Small, Therapeutic Strategy Lead: Site & Patient Networks
Charlie joined BTC Network in 2018 and previously held a variety of roles in business development. He provides integrated site network, patient engagement, and patient concierge strategies to Sponsor and CRO clients. Charlie specializes in business development, strategic planning, and contract negotiation.
